January 4, 2019
The House on Thursday passed a spending measure that would end a partial federal shutdown that affects some health agencies, but President Trump has said he would veto the bill, and without his support, Senate Majority Leader Mitch McConnell (R-Ky.) will not bring the bill for a vote in the Senate.
Sixteen states and the District of Columbia are appealing a federal judge's ruling that struck down the Affordable Care Act as unconstitutional.
A report from CDC's National Center for Health Statistics shows U.S. adults in 2016 on average weighed more than at any point since 1999, but had not grown taller.
HHS in new guidelines encourages health care providers to prescribe the overdose-reversal drug naloxone to patients taking prescription opioids who are at a high risk of overdosing on the drugs.
American Health Line rounds up the latest health care news in the states.
January 3, 2019
Dozens of drugmakers this month have increased or plan to increase U.S. list prices for their prescription drugs this year, according to two recent analyses.
Drugmakers Bristol-Myers Squibb and Celgene say they have reached an agreement for Bristol-Myers to purchase Celgene, and the combined company could become the fourth largest pharmaceutical company in the United States.
CMS in an advance notice details how the agency in 2020 plans to change the way it calculates risk scores used to determine payments for Medicare Advantage plans.
While the reduction in Medicare readmissions under the Hospital Readmissions Reduction Program (HRRP) initially might have "seemed like the win-win that policymakers had" sought, "a deeper look at [HRRP] reveals a few troubling trends," a group of cardiologists and health policy researchers write in a New York Times opinion piece.
January 2, 2019
A partial government shutdown—which started Dec. 22, 2018, and affects some federal health care agencies—occurred after the House, the Senate, and President Trump could not come to an agreement on a bill to extend funding for the federal government.
The Advisory Board Company. All Rights Reserved.